Laboratorios Farmaceuticos Rovi, S.A. (LON:0ILL)

LON:0ILL Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,482	2,663	2,788	1,707	3,475	1,881
Market Cap Growth	-38.46%	-4.50%	63.31%	-50.88%	84.77%	64.28%
Enterprise Value	2,559	2,762	2,797	1,687	3,415	1,916
Last Close Price	48.40	51.93	52.24	31.30	59.03	32.68
PE Ratio	21.19	23.52	18.86	9.64	27.03	34.38
PS Ratio	3.87	4.22	3.87	2.35	6.38	5.00
PB Ratio	4.95	5.54	5.91	3.69	8.79	5.62
P/TBV Ratio	5.36	5.92	6.28	3.92	9.42	6.18
P/FCF Ratio	35.64	40.68	54.04	10.30	37.89	278.47
P/OCF Ratio	20.96	23.29	28.37	8.10	27.69	44.79
EV/Sales Ratio	3.86	4.37	3.89	2.33	6.27	5.09
EV/EBITDA Ratio	14.12	16.73	13.54	7.01	20.69	23.87
EV/EBIT Ratio	16.26	18.69	14.69	7.50	22.57	28.55
EV/FCF Ratio	36.74	42.20	54.22	10.18	37.23	283.73
Debt / Equity Ratio	0.18	0.20	0.12	0.14	0.16	0.20
Debt / EBITDA Ratio	0.52	0.56	0.27	0.26	0.36	0.80
Debt / FCF Ratio	1.30	1.45	1.10	0.39	0.67	9.87
Asset Turnover	0.96	0.94	0.99	1.01	0.99	0.77
Inventory Turnover	0.90	0.89	1.07	1.10	1.14	0.95
Quick Ratio	1.15	0.99	0.83	1.04	1.35	1.10
Current Ratio	3.71	3.13	2.55	2.12	2.66	2.97
Return on Equity (ROE)	24.93%	24.33%	31.99%	40.24%	36.24%	17.54%
Return on Assets (ROA)	14.32%	13.69%	16.34%	19.68%	17.23%	8.63%
Return on Capital (ROIC)	17.36%	17.12%	22.81%	27.88%	22.69%	10.95%
Return on Capital Employed (ROCE)	26.50%	26.50%	36.60%	43.40%	33.20%	16.60%
Earnings Yield	4.72%	4.25%	5.30%	10.37%	3.70%	2.91%
FCF Yield	2.81%	2.46%	1.85%	9.71%	2.64%	0.36%
Dividend Yield	1.35%	1.49%	1.83%	3.67%	1.36%	1.04%
Payout Ratio	32.97%	41.24%	40.54%	25.55%	13.80%	15.89%
Buyback Yield / Dilution	-	3.73%	0.51%	3.50%	-0.03%	-0.37%
Total Shareholder Return	1.38%	5.21%	2.34%	7.16%	1.33%	0.67%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.